Depressive Disorder: all 4,847 studies

Page 42 of 49. Open to participants first (509), then studies with results posted, then the rest; newest registration first within each.

• Treatment of Postpartum Depression With Psychotherapy and Add-on SertralineCompletedNCT01028482Not applicable
• Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or DepressionCompletedNCT01028196
• Effect of Curcumin as Nutraceutical in Patients of DepressionCompletedNCT01022632Not applicable
• Sexuality After Reduction MammaplastyCompletedNCT01020422Not applicable
• Treatment for Depressed Primary Care PatientsCompletedNCT01014312Not applicable
• Depression Management at the WorkplaceCompletedNCT01013220Not applicable
• Randomized Clinical Trial of an Exposure-based Cognitive Therapy for DepressionStatus unknownNCT01012856Phase 2
• Community Clinic Test of Youth Anxiety TreatmentCompletedNCT01005836Not applicable
• Three Model Care Pathways for Postnatal DepressionCompletedNCT01002027Not applicable
• Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male SubjectsCompletedNCT01000857Phase 1
• Stress Reduction Intervention for Enhancing Treatment Outcome for Depressed Minority PatientsCompletedNCT00998959Not applicable
• Neurocognitive Enhancement in Major Depressive DisorderCompletedNCT00998569Not applicable
• Study of the Antidepressant Efficacy of a Combination Herbal Drug Preparation (NEURAPAS Balance)TerminatedNCT00997490Phase 3
• Cognitive Flexibility in Major Depression in the Course of Pharmacological and Psychotherapeutic TreatmentCompletedNCT00993876Not applicable
• Adjunctive Pregnenolone in Post-Traumatic Stress Disorder (PTSD) and Depression in Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) VeteransWithdrawnNCT00993629Phase 2
• The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?WithdrawnNCT00988663Not applicable
• "Assessment of Risk Factors for Depression Treatment at a Safety Net Clinic"Status unknownNCT00984685
• rTMS for Adolescents and Young AdultsWithdrawnNCT00984087Phase 2
• Treating Depression in Coronary Artery Disease With Omega-3 Fatty AcidsCompletedNCT00981383Phase 3
• N-methylglycine (Sarcosine) Treatment for DepressionCompletedNCT00977353Phase 2
• Psychophysiological Correlates of Mindfulness Based Cognitive Therapy (MBCT) in Recurrent DepressionCompletedNCT00974077Not applicable
• Magnetic Seizure Therapy (MST) for the Treatment of Major DepressionCompletedNCT00973934Phase 2
• Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Metastatic and/or Advanced Locoregional CancerCompletedNCT00972634
• Depression Outcomes Study of ExerciseCompletedNCT00964054Phase 1
• Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical ResponseWithdrawnNCT00963196Not applicable
• Photobiomodulation to Alter Cerebral Blood Flow and to Affect the Emotional Status of Patients With Major DepressionCompletedNCT00961454Phase 1
• Mirtazapine Reduces ICD Shocks in ICD Patients With Depression and AnxietyCompletedNCT00960830Not applicable
• Light, Ion, and Fluoxetine Efficacy (LIFE) in DepressionCompletedNCT00958204Phase 3
• Neurophysiologic Predictors of Outcome With rTMS Treatment of Major Depressive DisorderCompletedNCT00956514Phase 4
• Using a Preparation and Education Intervention to Reduce Postpartum Depression Among New Mothers (The MADE IT 2 Study)CompletedNCT00951717Not applicable
• Depression Screening in Patients Undergoing Radiation Therapy For CancerCompletedNCT00951184
• Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin TherapyWithdrawnNCT00951132Phase 2
• Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)CompletedNCT00951028Not applicable
• Cytokine-Associated Depression and Social PainCompletedNCT00949845Early Phase 1
• Young Adult and Teen Sleep StudyCompletedNCT00949689Phase 2
• Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major DepressionCompletedNCT00944996Not applicable
• Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum DepressionCompletedNCT00942721Phase 1
• Comparison of Vitamin B12 Supplementation to Selective Serotonin Reuptake Inhibitor (SSRI) Versus SSRI Antidepressant Treatment AloneStatus unknownNCT00939718Not applicable
• A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary CareCompletedNCT00939250Phase 4
• Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male SubjectsCompletedNCT00938184Phase 1
• Botulinum Toxin for the Treatment of DepressionCompletedNCT00934687Phase 2
• Assessment of Cognitive Functioning Before and After Treatment With DuloxetineCompletedNCT00933439Not applicable
• Citalopram Versus Citalopram Plus Pindolol in Major Depressive DisorderCompletedNCT00931775Phase 2
• GABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major DepressionCompletedNCT00931619
• Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent DepressionCompletedNCT00928980Not applicable
• Lithium and Standard Therapy in Resistant DepressionStatus unknownNCT00927550Phase 4
• Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression DisorderCompletedNCT00927173Not applicable
• Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder PatientsTerminatedNCT00926835Phase 4
• Assessing Anterior Cingulate Brain Activity in People With Late-Life DepressionCompletedNCT00926653
• Improving Representative Payeeship for People With Psychiatric Disabilities and Their FamiliesCompletedNCT00924976Not applicable
• Measuring Response to Depression TreatmentStatus unknownNCT00924183
• Effects of Electroconvulsive Therapy (ECT) on Serotonin-1A Receptor BindingCompletedNCT00922064Phase 4
• Repetitive Transcranial Magnetic Stimulation (rTMS) in DepressionTerminatedNCT00920322Phase 4
• Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)CompletedNCT00917059Phase 4
• Berlin Magnetic Seizure Therapy Depression Trial 01CompletedNCT00914680Phase 3
• Self-guided Depression Treatment on Long-duration Spaceflights: A Continuation StudyCompletedNCT00906581Not applicable
• Testing the Effectiveness of Adolescent Depression Prevention Programs (The OregonBlues Study)CompletedNCT00904891Phase 2/3
• Lamotrigine Augmentation in Resistant DepressionCompletedNCT00901407Not applicable
• Psychosocial Treatment for Women With Depression and PainCompletedNCT00895999Not applicable
• Bipolar Study of Seroquel XR With Pramipexole DihydrochlorideCompletedNCT00893841Phase 2
• Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive DisorderCompletedNCT00892463Phase 4
• Duloxetine for Major Depression in Peri-/Postmenopausal WomenStatus unknownNCT00889369Phase 4
• Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and WomenStatus unknownNCT00888862Phase 3
• Primary Care Patients With Depression for Internet-Based Social SupportCompletedNCT00886730Phase 1/2
• Antidepressant Effect of Deep Brain Stimulation in Parkinson's Disease PatientsCompletedNCT00885222Not applicable
• Telephone Cognitive-Behavioral Therapy (CBT) for Subthreshold Depression and Presenteeism in WorkplaceCompletedNCT00885014Phase 2/3
• The Efficacy of Parent Involvement in the Treatment of Adolescent DepressionCompletedNCT00883519Phase 1/2
• Dialogical and Narrative Processes in Couple Therapy for DepressionCompletedNCT00883207Phase 2/3
• Study Evaluating Effexor XR in Chinese Subjects With Major Depressive DisorderWithdrawnNCT00878748Phase 4
• Life Improvement Following Traumatic Brain InjuryCompletedNCT00878150Not applicable
• Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major DepressionCompletedNCT00873795Not applicable
• Practicing Alternative Techniques to Heal From Depression: The PATH-D StudyCompletedNCT00871299Not applicable
• Ultrabrief Pulsewidth Electroconvulsive Therapy (ECT)CompletedNCT00870805Phase 4
• Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for DepressionCompletedNCT00869765Phase 2
• Designing and Testing a Family Therapy for Adolescent DepressionCompletedNCT00867919Phase 1
• A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in DepressionCompletedNCT00866593Phase 2/3
• Neuroimaging for DepressionTerminatedNCT00864630Not applicable
• St. John's Wort Extract LI 160 for the Treatment of Atypical DepressionCompletedNCT00861978Phase 3
• Affective Processing in Depression and EpilepsyTerminatedNCT00855725
• Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive DisorderCompletedNCT00855530Phase 3
• Antenatal Relaxation Group for Anxiety and Depression ManagementStatus unknownNCT00855192Not applicable
• Pilot Study of a Self-help Intervention for Depression in Patients With a Chronic DiseaseCompletedNCT00854984Not applicable
• Psychosocial Treatment of Depression in Parkinson's DiseaseStatus unknownNCT00853346Not applicable
• The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)CompletedNCT00851669Phase 2
• Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals.CompletedNCT00845455
• Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive SymptomsCompletedNCT00844974Not applicable
• Vocal Acoustic Biomarkers in DepressionCompletedNCT00844948
• Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)CompletedNCT00844922Phase 2
• Women's Depression Treatment StudyCompletedNCT00843700Phase 2
• Food and Relative Bioavailability StudyCompletedNCT00843011Phase 1
• Evaluation of a Psychoeducation Group Program for Mild/Moderate DepressionStatus unknownNCT00841737Not applicable
• Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)CompletedNCT00839176Phase 2
• Acupuncture for Residual Insomnia Associated With Major Depressive DisorderCompletedNCT00838994Not applicable
• Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic DepressionStatus unknownNCT00837564Phase 3
• An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar DepressionCompletedNCT00835107Phase 4
• Early Psychosocial Stimulation Program for Children of Depressed MothersCompletedNCT00835016Not applicable
• Use of Conversation and Acoustic Signals in Measuring Depression SeverityCompletedNCT00831935
• Serum Markers as a Bioassay for Unipolar DepressionCompletedNCT00825799
• Efficacy and Safety of SR58611 Compared to Placebo and ParoxetineCompletedNCT00825058Phase 3
• Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and ParoxetineCompletedNCT00825019Phase 3

← Depressive Disorder overview